14.03.2024 - andera Life Sciences - Nos communiqués

Tubulis, au portefeuille d’Andera Partners, annonce la finalisation de sa levée de série B2 d’…

Combined Shape

14.03.2024 - andera Life Sciences - Nos communiqués

Amolyt Pharma, au portefeuille d’Andera Partners, annonce son acquisition par AstraZeneca

Combined Shape

21.02.2024 - andera Life Sciences - Nos communiqués

MMI Raises $110 Million in Series C Financing

Combined Shape

12.02.2024 - andera Life Sciences - Recrutement

Internship Offer – Andera Life Sciences

14.11.2023 - andera Life Sciences - Nos communiqués

Andera Partners co-mène le financement de série C sursouscrit de 67,5 millions d’euros (72 mil…

Combined Shape

27.10.2023 - andera Life Sciences - Nos communiqués

JenaValve Announces Late-Breaking Data from the ALIGN-AR Pivotal Trial Meeting Safety and Efficacy E…

Combined Shape

11.10.2023 - andera Life Sciences - Nos communiqués

Agomab Raises $100 Million Series C to Advance Fibrosis-focused Pipeline

Combined Shape

05.10.2023 - andera Life Sciences - Nos communiqués

Agomab Receives FDA Fast Track Designation for AGMB-129 in Fibrostenosing Crohn’s Disease and Starts…

Combined Shape

24.07.2023 - andera Life Sciences - Nos communiqués

Crescendo Biologics secures $32M and announces expansion of CB307 Phase 1b trial in PSMA+ solid tumo…

Combined Shape

27.06.2023 - andera Life Sciences - Nos communiqués

Allecra Therapeutics Submits New Drug Application to the U.S. FDA for EXBLIFEP® for the Treatment of…

Combined Shape

01.06.2023 - andera Life Sciences - Nos communiqués

Inotrem announces publication of two key articles on nangibotide Phase II programs in peer-reviewed…

Combined Shape

15.05.2023 - andera Life Sciences - Nos communiqués

Andera Partners co-dirige une série A de 40 millions d’euros pour Dualyx, une biotech belge qu…

Combined Shape

20.04.2023 - andera Life Sciences - Nos communiqués

Tubulis Announces Strategic License Agreement with Bristol Myers Squibb to Develop Next Generation A…

Combined Shape

18.04.2023 - andera Life Sciences - Nos communiqués

Andera Partners soutient Ariceum Therapeutics dans l’extension de son financement de série A à…

Combined Shape

13.04.2023 - andera Life Sciences - Nos communiqués

BioVentrix® clôture un tour de financement de série A de 48,5 millions de dollars

Combined Shape

29.03.2023 - andera Life Sciences - Nos communiqués

Grey Wolf Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of GRWD5769 in…

Combined Shape

15.03.2023 - andera Life Sciences - Nos communiqués

Andera Partners co-dirige une extension de tour de table de 25 millions de dollars pour FIRE1

Combined Shape

03.03.2023 - andera Life Sciences - Nos communiqués

Flamingo Therapeutics and Dynacure Announce Merger to Create Leading RNA Therapeutics Company Focuse…

Combined Shape

13.02.2023 - andera Life Sciences - Nos communiqués

Mineralys Therapeutics rentre en Bourse sur le Nasdaq pour un montant de 192 millions de dollars

Combined Shape

02.02.2023 - andera Life Sciences - Nos communiqués

Agomab Reports Positive Phase 1 Results with AGMB-129, a GI-restricted ALK5 Inhibitor for Fibrosteno…

Combined Shape

26.01.2023 - andera Life Sciences - Nos communiqués

Andera Partners participe au financement de la Série B de 49 millions de dollars de Grey Wolf Therap…

Combined Shape

10.01.2023 - andera Life Sciences - Nos communiqués

Andera Partners réalise un investissement dans SoniVie, une société medtech développant un dispositi…

Combined Shape

09.01.2023 - andera Life Sciences - Nos communiqués

Andera Partners participe au financement de série C de €130 millions d’Amolyt Pharma

Combined Shape

20.10.2022 - andera Life Sciences - Nos communiqués

T-knife Therapeutics Announces Dosing of First Patient with TK-8001 in the IMAG1NE Phase 1/2 Clinica…

Combined Shape

10.10.2022 - andera Life Sciences - Nos communiqués

Andera Partners, annonce aujourd’hui la finalisation de la levée de son fonds BioDiscovery 6 à 456 m…

Combined Shape

03.10.2022 - andera Life Sciences - Nos communiqués

Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics to Accelerate Growth in Genomic…

Combined Shape

16.09.2022 - andera Life Sciences - Nos communiqués

JenaValve Completes Enrollment in the ALIGN-ARIDE Clinical Trial

Combined Shape

15.09.2022 - andera Life Sciences - Nos communiqués

TRiCares Raises €47m in a First Closing of its Series C

Combined Shape

12.09.2022 - andera Life Sciences - Nos communiqués

Agomab Therapeutics Selected as One of Fierce Biotech’s « Fierce 15 » Companies of 2022

Combined Shape

20.07.2022 - andera Life Sciences - Nos communiqués

Medical Microinstruments Secures $75M to Advance Robotic Microsurgery

Combined Shape

13.07.2022 - andera Life Sciences - Nos communiqués

Agomab Raises Additional $40.5 Million Through Series B Extension Bringing Total Amount to $114M

Combined Shape

07.07.2022 - andera Life Sciences - Nos communiqués

Andera Partners renforce son équipe Life Sciences en accueillant un nouvel associé

Combined Shape

13.06.2022 - andera Life Sciences - Nos communiqués

ImCheck annonce la clôture d’un tour de financement de 96 millions d’euros (103 millions de do…

Combined Shape

08.06.2022 - andera Life Sciences - Nos communiqués

Andera Partners accompagne Mineralys Therapeutics dans son tour de financement de série B sursouscri…

Combined Shape

17.05.2022 - andera Life Sciences - Nos communiqués

TRiCares Announces Successful Implantation of Minimally Invasive Topaz Tricuspid Heart Valve Replace…

Combined Shape

03.05.2022 - andera Life Sciences - Nos communiqués

Andera Partners accompagne Tubulis dans un financement de série B de 60 millions d’euros pour…

Combined Shape

26.04.2022 - andera Life Sciences - Nos communiqués

Successful first in human implantation of Topaz Tricuspid Heart Valve Replacement System

Combined Shape

07.04.2022 - andera Life Sciences - Nos communiqués

Andera Partners cède ReViral, société de son portefeuille dédié aux sciences de la vie, à Pfizer

Combined Shape

22.03.2022 - andera Life Sciences - Nos communiqués

Evommune Initiates Phase 1 Study to Evaluate Safety of EVO101, an IRAK4 Inhibitor, in Healthy Volunt…

Combined Shape

22.02.2022 - andera Life Sciences - Nos communiqués

Andera Partners accompagne TargED Biopharmaceuticals dans son financement de série A de 39 millions…

Combined Shape

19.01.2022 - andera Life Sciences - Nos communiqués

JenaValve Announces Strategic Investment and Licensing Agreement with Peijia Medical Limited

Combined Shape

13.01.2022 - andera Life Sciences - Nos communiqués

Allecra Therapeutics and ADVANZ PHARMA Sign Exclusive License and Supply Agreement for Allecra’s Ant…

Combined Shape

10.01.2022 - andera Life Sciences - Nos communiqués

BioNTech and Crescendo Biologics announce global collaboration to develop multi-specific precision i…

Combined Shape

22.11.2021 - andera Life Sciences - Nos communiqués

Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology

Combined Shape

28.10.2021 - andera Life Sciences - Nos communiqués

Agomab Therapeutics to Acquire Origo Biopharma

Combined Shape

26.10.2021 - andera Life Sciences - Nos communiqués

Andera Partners accompagne Exciva dans une série A pour combattre la maladie d’Alzheimer

Combined Shape

16.09.2021 - andera Life Sciences - Nos communiqués

Andera Partners mène la série B de 80 millions de dollars de Amolyt Pharma aux côtés de Sectoral Ass…

Combined Shape

09.09.2021 - andera Life Sciences - Nos communiqués

Andera Partners, investisseur de référence du financement de série A de US$ 83 millions d’Evommune I…

Combined Shape

02.08.2021 - andera Life Sciences - Nos communiqués

T-knife Therapeutics annonce un financement de série B de 110 millions de dollars

Combined Shape

27.07.2021 - andera Life Sciences - Nos communiqués

Artios annonce un financement de série C de 153 millions de dollars

Combined Shape

13.07.2021 - andera Life Sciences - Nos communiqués

Inotrem poursuit son programme pour le traitement des formes sévères de Covid-19

Combined Shape

05.07.2021 - andera Life Sciences - Nos communiqués

1ères implantations réalisées avec succès chez l’homme du système Topaz développé par TRiCares

Combined Shape

23.06.2021 - andera Life Sciences - Nos communiqués

Poxel annonce l’approbation de TWYMEEG® pour le traitement du diabète de type 2

Combined Shape

04.05.2021 - andera Life Sciences - Nos communiqués

Life Sciences portfolio company Gamamabs signs an agreement with Exelixis

Combined Shape

27.04.2021 - andera Life Sciences - Andera Partners - Nos communiqués

Andera Partners renforce sa présence dans la région DACH

Combined Shape

07.04.2021 - andera Life Sciences

Artios Pharma announces collaboration with Novartis

02.03.2021 - andera Life Sciences - Nos communiqués

ReViral and LianBio Announce Exclusive Collaboration

Combined Shape

10.02.2021 - andera Life Sciences - Nos communiqués

MedLumics closes upsized EUR 18M financing round and appoints new Chairman

Combined Shape

13.01.2021 - andera Life Sciences

MMI appoints healthcare industry veteran Mark Toland as CEO

07.01.2021 - andera Life Sciences - Nos communiqués

AM-Pharma Announces Enrollment and Financing of COVID-19 Cohort in Phase III REVIVAL Trial

Combined Shape

05.01.2021 - andera Life Sciences - Nos communiqués

Andera Life Sciences cède Arvelle Therapeutics à Angelini Pharma

Combined Shape

04.01.2021 - andera Life Sciences - Nos communiqués

L’étude d’Inotrem en Phase IIa dans la COVID-19 est déclarée « priorité nationale de recherche » par…

Combined Shape

12.10.2020 - andera Life Sciences - Nos communiqués

Medlumics lands a 14M€ new financing round

Combined Shape

28.08.2020 - andera Life Sciences - Nos communiqués

Reviral raises $44 million in Series C financing

Combined Shape

06.08.2020 - andera Life Sciences - Nos communiqués

T-knife completes €66m Series A financing

Combined Shape

23.07.2020 - andera Life Sciences - Revue de presse

COVID-19 : évaluer nangibotide chez les malades sous ventilation mécanique atteints de COVID-19

Combined Shape

11.06.2020 - andera Life Sciences - Nos communiqués

BioDiscovery cède Corvidia à Novo Nordisk

Combined Shape

06.05.2020 - andera Life Sciences - Nos communiqués

Appointment of Michael H. Carrel as chairman of the Axonics board of directors.

Combined Shape

06.05.2020 - andera Life Sciences - Nos communiqués

 Axonics Modulation Technologies reports financial results for the 1st quarter 2020 and provides an…

Combined Shape

02.04.2020 - andera Life Sciences - Nos communiqués

Dynacure Announces €50M ($55M) Series C Financing

Combined Shape

01.04.2020 - andera Life Sciences - Nos communiqués

AM-Pharma Increases Funding to €163m for Phase-III Trial of recAP in SA-AKI

Combined Shape

28.02.2020 - andera Life Sciences - Nos communiqués

Allecra Therapeutics announces positive top-Line results for phase 3 ALLIUM clinical trial of EXBLIF…

Combined Shape

21.11.2019 - andera Life Sciences - Nos communiqués

Inotrem annonce le recrutement du 1er patient dans l’étude de Phase IIb pour évaluer son produit dan…

Combined Shape

11.10.2019 - andera Life Sciences - Nos communiqués

BioDiscovery invests in AgomAb Therapeutics

Combined Shape

16.07.2019 - andera Life Sciences - Nos communiqués

BioDiscovery mène le dernier tour de table de 116 M€ d’AM-Pharma aux côtés de LSP

Combined Shape

14.02.2019 - andera Life Sciences - Nos communiqués

A syndicate of international investors finance Arvelle Therapeutics

Combined Shape

11.02.2019 - andera Life Sciences - Nos communiqués

Grey Wolf Therapeutics completes £10 million series A financing with Andera Partners and Canaan

Combined Shape

05.11.2018 - andera Life Sciences - Nos communiqués

Crescendo Biologics announces early licensing by Takeda

Combined Shape

05.11.2018 - andera Life Sciences - Nos communiqués

Résultats prometteurs pour le candidat-médicament principal de Genkyotex (BioDiscovery 3) dans une m…

Combined Shape

02.08.2018 - andera Life Sciences - Nos communiqués

Artios Pharma Announces $86 million (£65 million) Series B Financing

Combined Shape

06.07.2018 - andera Life Sciences - Nos communiqués

BioDiscovery invests in Dynacure to advance lead program into clinical development

Combined Shape

04.06.2018 - andera Life Sciences - Nos communiqués

ENYO Pharma raises €40 million in Series B fundraising

Combined Shape

04.06.2018 - andera Life Sciences - Nos communiqués

TRiCares réalise une Série B de €22 Millions ($25.4 Millions) pour le développement de son traitemen…

Combined Shape

22.05.2018 - andera Life Sciences - Nos communiqués

GamaMabs Pharma présente au congrès ASCO 2018 des résultats de son premier essai clinique de GM102 d…

Combined Shape

02.05.2018 - andera Life Sciences - Nos communiqués

Deuxième tour de financement de Crescendo Biologics

Combined Shape

25.04.2018 - andera Life Sciences - Nos communiqués

2nd tour de financement à €60m pour Corvidia Therapeutics

Combined Shape

25.04.2018 - andera Life Sciences - Nos communiqués

Corvidia Therapeutics Secures $60 Million in Series B Funding

Combined Shape